While I agree with others that SRT is fairly easy procedure (just had mine completed a couple of weeks ago), let me be a devil's advocate and ask why you need to jump into SRT when your PSA is still so low. Give it a bit of time and see what the next test will show. The textbook definition of recurrence is two consecutive rises above 0.2. You are not there yet and may not ever get there (God willing).
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">Father died from poorly differentiated PCa @ 78 - normal PSA and DRE<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p>
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">5 biopsies over 4 years negative while PSA going from 3.8 to 28<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'"><o:p></o:p>
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">Dx Nov 2007, age 46, PSA 29, Gleason 4+4=8<o:p></o:p>
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">Decided to participate in clinical trial at Duke - 6 rounds of chemo (Taxotere+Avastin)
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'"><SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">PSA prior to treatment<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'"> on <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">1/8/2008 is <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">33.90, bounced on 1/31/2008 to <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">38.20, and down at the end of the treatment (4/24/2008) to <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">20.60
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'"><SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'"><SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">RRP at Duke (Dr. Moul) on 6/16/2008, <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">Gleason downgraded 4+3=7, <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">T3a N0MX, focal extraprostatic extension, two small positive margins<o:p></o:p>
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">PSA undetectable for 8 months, then <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">2/6/2009<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">-<SPAN style="COLOR: black">0.10, 4<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">/26/2009<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">-<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">0.17, 5/22/2009<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">-<SPAN style="COLOR: black">0.20, <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 'Times New Roman'">6/11/2009<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">-<SPAN style="COLOR: black">0.27<o:p></o:p>
<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">Salvage IMRT + 6 Months ADT: Casodex started 6/12/2009<SPAN style="FONT-FAMILY: 'Garamond', 'serif'; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">, Lupron 6/22/2009, PSA 6/25/2009-0.1, T=516, 7/23/2009-<0.05, T<10, 10/21/2009-<0.05, T<10, salvage <SPAN style="FONT-FAMILY: 'Garamond', 'serif'; COLOR: black; FONT-SIZE: 10pt; mso-bidi-font-family: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'">IMRT to prostate bed and pelvis. 72gy over 40 treatments finished 10/21/2009.